Using circulating biomarkers to stage hepatocellular carcinoma: Pitfalls and limitations.
Sign Up to like & getrecommendations! Published in 2020 at "Hepatology"
DOI: 10.1002/hep.31618
Abstract: We read with interest the paper "HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk" by Dr. Morris et al. published in an upcoming issue of Hepatology.1 It is an elegant study… read more here.
Keywords: hepatocellular carcinoma; circulating biomarkers; biomarkers stage; using circulating ... See more keywords